Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy.
about
Clonazepam for neuropathic pain and fibromyalgia in adultsNeuromodulators for pain management in rheumatoid arthritisNeuromodulators for pain management in rheumatoid arthritisGabapentin for acute and chronic painAntidepressants for neuropathic painGabapentin for acute and chronic painAntidepressants for neuropathic painEfficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic painRandomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats.Voltage-gated Na+ channels in neuropathic pain.The treatment of spinal metastases.Neuroimaging revolutionizes therapeutic approaches to chronic painCurrent aproach to cancer pain management: Availability and implications of different treatment options.Anticonvulsants in central pain.Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitineUp-regulation of spinal glutamate transporters contributes to anti-hypersensitive effects of valproate in rats after peripheral nerve injuryGynecologic management of neuropathic pain.Newer anticonvulsant drugs in neuropathic pain and bipolar disorder.Role of topiramate for the treatment of painful diabetic peripheral neuropathy.Practical management of patients with painful diabetic neuropathy.Antiepileptic use for epilepsy and nonepilepsy disorders: A population-based study (1998-2013).Chronic administration of ketamine for analgesia.Gene therapy applications for the treatment of neuropathic pain.Advanced formulation design: improving drug therapies for the management of severe and chronic pain.Sodium channel blockers for neuropathic pain.Antiepileptic drugs for the treatment of neuropathic pain: a systematic review.Topiramate and cognitive impairment: evidence and clinical implications.Paraneoplastic nerve hyperexcitability.Current and Emerging Medical Therapies for Gastroparesis.Pregabalin in Chemotherapy Induced Neuropathic Pain.Comparison of the efficacy of carbamazepine, gabapentin and lamotrigine for neuropathic pain in rats.Painful posttraumatic trigeminal neuropathy: a case report of relief with topiramate.Gabapentin induced cholestasis.Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse.The antinociceptive effect of systemic gabapentin is related to the type of sensitization-induced hyperalgesia.Gabapentin in the management of dysautonomia following severe traumatic brain injury: a case series.Antinociceptive effects of NCX-701 (nitro-paracetamol) in neuropathic rats: enhancement of antinociception by co-administration with gabapentin.Topiramate and weight loss in patients with neurodevelopmental disabilities.Neuropathic pain and dry eye.
P2860
Q24197928-E83DE02E-3DE6-4CC3-9A60-9BD1FB436E53Q24203885-37FF17DA-A64D-4847-8C57-CA52A8F3BC7CQ24235149-A09FF485-1915-45E2-A637-0F50414628D5Q24235992-B8882E02-AFB4-44D2-A2F5-B47A1DAACDC9Q24243292-C3772E1A-D5C8-4F6D-B32D-6F4362567DA3Q24246411-AAAAE0BE-6688-4731-87F3-0F9857139763Q24246575-135A3811-4FC6-4ED3-9C51-02239C549149Q24670430-E0C44E17-F79E-4029-9C6A-904F96C4A10FQ24802765-2670008F-BCBE-4F53-A037-E3ACD8E70BB8Q30311218-D91F0177-CD0D-4DCA-A8EA-C405CB07F3EBQ30443511-F48361AA-E5BC-49E5-8B49-83E1419C6145Q34565775-7D8DE4D8-10E9-4488-96E5-952F162530C7Q34582857-420FC2B4-22C4-45BB-BD84-E4867C975CB4Q34779398-204EDE2B-39D0-4980-9D52-02CBF9029092Q34974796-1BAC951F-AE9D-4AE7-949B-AF4FA373BC10Q34997110-197B0221-98E2-47CB-B5F2-394A97F4A9A4Q35175824-39B80E52-C29D-45FE-B7EB-A41E9FBE1E09Q35489433-6B9E3CA5-19FD-4451-AEF7-830E6AED13A4Q35592152-FDE1A683-106B-4906-8622-754BFA2D54C8Q35906320-0130C962-0308-43B5-8933-DCEBBBA9E718Q36229369-53DF768E-DF51-4B8D-A26F-69019E15220FQ36661735-67B5C22B-E738-4B8A-80EF-6E581697EA05Q36790314-89FA5E6E-6AAD-4E9C-A5D4-801108098A54Q36817045-AB38D110-A052-4C08-BE1B-1C6F4F0B990DQ37095373-A994E7AB-7BC0-485B-B056-F1A1F54D1F6AQ37729164-B80FD07F-ADBF-46D5-82B5-27C16B65E1E5Q38006872-5DBA2186-770C-4F61-8550-07C0AC98C263Q38235953-C163C5EE-7653-4712-A280-24C92CC3BC0EQ38319391-ED57B199-54C5-44F7-BA30-0C8C47EDAC07Q38617535-BA7E1722-5386-47A6-A918-D13D8313921EQ38644156-EDB93A9E-B9E8-4F37-A664-A5E631A564B3Q38727526-846B8763-FA8C-4843-B6F1-93A2CF34872FQ39339500-6A134F7F-2940-4D98-8C2E-FF86CFC96482Q39648340-2B149169-D6F9-4043-9D8D-1569F95F5888Q41973537-458A898D-5AE8-4E3B-93AE-8D79C5E140ABQ42105698-FA637BE2-F5F0-49B4-9E89-348EF8C4E944Q42181136-2A672924-0A05-4767-88CA-042DAA7A9E37Q42577505-6526DF3A-B572-4836-AEF4-0FFCE8DFE6A3Q44069748-999C5DE6-082A-4F1F-9FA5-43FAAA5FD786Q47739620-96826734-E11A-45CC-AB9A-F7B3B2FB78D9
P2860
Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Anticonvulsants for neuropathi ...... f action and place in therapy.
@ast
Anticonvulsants for neuropathi ...... f action and place in therapy.
@en
Anticonvulsants for neuropathi ...... f action and place in therapy.
@nl
type
label
Anticonvulsants for neuropathi ...... f action and place in therapy.
@ast
Anticonvulsants for neuropathi ...... f action and place in therapy.
@en
Anticonvulsants for neuropathi ...... f action and place in therapy.
@nl
prefLabel
Anticonvulsants for neuropathi ...... f action and place in therapy.
@ast
Anticonvulsants for neuropathi ...... f action and place in therapy.
@en
Anticonvulsants for neuropathi ...... f action and place in therapy.
@nl
P2093
P1433
P1476
Anticonvulsants for neuropathi ...... f action and place in therapy.
@en
P2093
Backonja MM
Tremont-Lukats IW
P304
P356
10.2165/00003495-200060050-00005
P577
2000-11-01T00:00:00Z
P6179
1033807453